TCG Crossover Management, LLC
Position in TRDA — Entrada Therapeutics, Inc.
CIK 1839948
PALO ALTO, CA
Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,803,292
-$21,064,958 QoQ
Shares Held
1,060,230
-53.7% QoQ
Ownership
2.72%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#7
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TCG Crossover Management, LLC holds $3,891,479,135 across 48 Biotechnology names. TRDA ranks #42 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
6,007,834 | $800,603,958 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
9,081,201 | $283,878,343 | |
| 3 | CGON |
CG Oncology, Inc.
|
3,670,206 | $260,768,136 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
4,854,436 | $187,866,673 | |
| 5 | IMVT |
Immunovant, Inc.
|
4,457,988 | $171,766,277 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,900,582 | $168,733,669 | |
| 7 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,676,624 | $163,437,307 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,062,049 | $124,334,076 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,803,292 | 1,060,230 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $28,868,250 | 2,287,500 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,468,669 | 2,088,392 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,392,739 | 584,955 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,930,897 | 584,955 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,287,993 | 584,955 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,113,871 | 584,955 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,347,580 | 584,955 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,335,608 | 584,955 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,288,812 | 584,955 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,826,970 | 584,955 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,242,289 | 584,955 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,856,218 | 584,955 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,481,847 | 584,955 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,908,591 | 584,955 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,120,898 | 642,189 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,083,792 | 663,694 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,232,086 | 663,694 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,362,441 | 663,694 | Shares | Sole | 2022-02-18 | |
| No filing history on record for this holder in this stock. | ||||||